Shares for U.S. drug suppliers rose on Monday after a report by CNBC that Amazon is shelving its plan to sell pharmaceuticals to hospitals. The company’s B2B platform, Amazon Business, will focus on selling less sensitive medical supplies due to a reported lack of contracts and infrastructure.

You can read the full report from CNBC’s Eugene Kim and Christina Farr here.